L3VLUP
ProSign in

AVTR · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

AVTRLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • AVTR
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterAVTRLLY
Q3 202022 holders, $2.7bn33 holders, $14.1bn
Q4 202021 holders, $4.2bn29 holders, $17.3bn
Q1 202115 holders, $4.2bn24 holders, $23.0bn
Q2 202112 holders, $5.2bn24 holders, $27.8bn
Q3 202117 holders, $6.3bn31 holders, $29.9bn
Q4 202116 holders, $6.6bn31 holders, $34.7bn
Q1 202222 holders, $5.5bn24 holders, $35.3bn
Q2 202220 holders, $5.4bn33 holders, $42.7bn
Q3 202223 holders, $2.2bn31 holders, $43.4bn
Q4 202220 holders, $2.0bn31 holders, $46.6bn
Q1 202316 holders, $1.5bn33 holders, $44.3bn
Q2 202314 holders, $1.4bn37 holders, $59.6bn
Q3 202318 holders, $1.9bn44 holders, $67.6bn
Q4 202314 holders, $3.0bn45 holders, $73.6bn
Q1 202416 holders, $3.1bn41 holders, $95.3bn
Q2 202413 holders, $2.1bn43 holders, $110bn
Q3 20249 holders, $2.6bn45 holders, $107bn
Q4 202411 holders, $2.8bn46 holders, $93.9bn
Q1 202510 holders, $2.2bn42 holders, $98.4bn
Q2 202510 holders, $2.0bn43 holders, $93.2bn
Q3 202510 holders, $1.8bn39 holders, $86.7bn
Q4 20257 holders, $1.8bn41 holders, $123bn
Q1 20269 holders, $1.3bn39 holders, $106bn
Q2 20265 holders, $1.5bn44 holders, $132bn
AVTR

Avantor Inc

Holders
10
Reported value
$2.0bn
Buyers
7
Sellers
4

Breadth +3 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
43
Reported value
$93.2bn
Buyers
25
Sellers
22

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 43 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only AVTR (0)

None.

Only LLY (33)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Artisan Partners LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Harris Associates LP, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, Neuberger Berman Group LLC, Polen Capital Management LLC, Quantbot Technologies LP, Rokos Capital Management LLP, and 8 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →